Krystal Biotech

-$1.29 (-2.18%) Today
$0.00 (0.00%) As of 9:26 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KRYS and other ETFs, options, and stocks.

About KRYS

Krystal Biotech, Inc. is a clinical-stage biotechnology company, which focuses on the development of redosable gene therapies to improve the lives of patients living with rare diseases. The firm developed a proprietary gene delivery platform that enables off-the-shelf treatments for serious rare diseases with significant unmet need, initially in the areas of dermatology and respiratory diseases.

CEO
Krish S. Krishnan
Employees
119
Headquarters
Pittsburgh, Pennsylvania
Founded
2016

KRYS Key Statistics

Market cap
1.48B
Price-Earnings ratio
—
Dividend yield
—
Average volume
178.06K
High today
$60.44
Low today
$57.23
Open price
$60.17
Volume
91.03K
52 Week high
$102.99
52 Week low
$38.86

KRYS News

Simply Wall StMay 17

Here's What Krystal Biotech, Inc.'s Shareholder Ownership Structure Looks Like - Simply Wall St

A look at the shareholders of Krystal Biotech, Inc. ( ) can tell us which group is most powerful. Institutions will often hold stock in bigger companies, and we

KRYS Earnings

-$0.99
-$0.66
-$0.33
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.99 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure